Revenue
2022
2023
2024
2025
Cambridge Nutritional Sciences plc (CNSL)
Price£0.0185Cached quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | £8.3M | £9.8M | £7.5M | £8.5M |
| Operating expenses | £5.8M | £6.6M | £6.3M | £5.7M |
| Operating income | −£395,000 | −£535,000 | −£2.7M | −£592,000 |
| Operating margin | −4.74% | −5.47% | −35.98% | −6.93% |
| EBITDA | £2.2M | −£73,000 | −£2.6M | £360,000 |
| EBITDA margin | 26.39% | −0.75% | −35.09% | 4.22% |
| Net income | £1.6M | −£328,000 | −£3.9M | −£11.3M |
| Net profit margin | 18.80% | −3.36% | −51.15% | −132.72% |
| Basic EPSper basic share | £0.01 | -£0.00 | -£0.02 | -£0.06 |
| Diluted EPSper diluted share | £0.01 | -£0.00 | -£0.02 | -£0.06 |
Owners
Reported major voting-rights holders
7.66%of voting rights
Spreadex LTDNotified Oct 5, 2026
View holders
| Holder | Voting rights |
|---|---|
Spreadex LTD | 7.66%Oct 5, 2026 · 18.23M votes |
Cantor Fitzgerald Europe | 4.60%Mar 30, 2026 · 10.95M votes |
These are threshold-crossing notices, not a complete ownership register. Percentages show issuer voting rights held through the listed share class, exclude financial instruments, and come from different dates. Positions may overlap.
Gray completes the 100% scale; it is not an estimate of other owners.
Source: FCA National Storage Mechanism ↗Updated Oct 21, 2026